Fri, 29 Aug 2008 11:09:17 -0400 PeerView Press http://www.peerviewpress.com Podcast Maker v1.3.3 - http://www.lemonzdream.com/podcastmaker PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. Thought leader perspectives on current clinical advances in medicine PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. 2006 PeerView Press, 24 West 40th Street, Suite 950, New York, NY 10018 webmaster@peerviewpress.com http://podcast.peerviewpress.com/aids/aidsalbumart_144.jpg http://www.peerviewpress.com 144 144 Science & Medicine CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, AIDS, HIV no PeerView Press In this activity, experts in the treatment of HIV discuss the importance of treatment adherence for patients with this condition. Factors associated with nonadherence are explored, and strategies to improve adherence are highlighted. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV discuss the importance of treatment adherence for patients with this condition. Factors associated with nonadherence are explored, and strategies to improve adherence are highlighted. http://podcast.peerviewpress.com/aids/PA04263FCr408.mp3 http://podcast.peerviewpress.com/aids/PA04263FCr408.mp3 Fri, 29 Aug 2008 11:02:47 -0400 Science no 00:21:22 Adherence, antiretrovirals, PI, NNRTI, NRTI, pill burden, regimen complexity, forgiveness, food, alcohol PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA04263FCCMEinfo.pdf http://podcast.peerviewpress.com/aids/PA04263FCCMEinfo.pdf Fri, 29 Aug 2008 11:02:45 -0400 Science no 00:00:00 Adherence, antiretrovirals, PI, NNRTI, NRTI, pill burden, regimen complexity, forgiveness, food, alcohol PeerView Press In this activity, experts evaluate recent data on the efficacy and safety of NNRTI-based regimens for treatment-naïve patients with HIV. An analysis of how patient-related and medication-related factors play a role in selecting initial NNRTI-based regimens is featured. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts evaluate recent data on the efficacy and safety of NNRTI-based regimens for treatment-naïve patients with HIV. An analysis of how patient-related and medication-related factors play a role in selecting initial NNRTI-based regimens is featured. http://podcast.peerviewpress.com/aids/PA04427FCr401.mp3 http://podcast.peerviewpress.com/aids/PA04427FCr401.mp3 Tue, 17 Jun 2008 11:13:47 -0400 Science no 00:20:09 AIDS, HIV, NNRTIs, DHHS, efavirenz, nevirapine, treatment-naïve, HAART PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA04427FCCMEinfo.pdf http://podcast.peerviewpress.com/aids/PA04427FCCMEinfo.pdf Tue, 17 Jun 2008 11:11:49 -0400 Science no 00:00:00 AIDS, HIV, NNRTIs, DHHS, efavirenz, nevirapine, treatment-naïve, HAART PeerView Press In this activity, experts in the treatment of HIV discuss recent issues on when to initiate antiretroviral agents and how and when to switch therapy. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV discuss recent issues on when to initiate antiretroviral agents and how and when to switch therapy. http://podcast.peerviewpress.com/aids/PA04259FCe019.mp3 http://podcast.peerviewpress.com/aids/PA04259FCe019.mp3 Fri, 30 May 2008 09:58:35 -0400 Science no 00:39:06 AIDS, HIV, treatment failure, virologic failure, immunologic failure, clinical progression, PI, NNRTI PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA04259FCCMEinfo.pdf http://podcast.peerviewpress.com/aids/PA04259FCCMEinfo.pdf Fri, 30 May 2008 09:58:32 -0400 Science no 00:00:00 AIDS, HIV, treatment failure, virologic failure, immunologic failure, clinical progression, PI, NNRTI PeerView Press In this activity, experts in the treatment of HIV present recent data on the efficacy and safety of a number of antiretroviral regimens used in the management of treatment-naïve patients. A discussion on the clinical implications of updated DHHS guidelines for the initiation of treatment is featured. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV present recent data on the efficacy and safety of a number of antiretroviral regimens used in the management of treatment-naïve patients. A discussion on the clinical implications of updated DHHS guidelines for the initiation of treatment is featured. http://podcast.peerviewpress.com/aids/PA04181FCs474.mp3 http://podcast.peerviewpress.com/aids/PA04181FCs474.mp3 Wed, 30 Apr 2008 14:41:48 -0400 Science no 00:29:40 AIDS, HIV, DHHS, CROI, lipoatrophy, SMART, CASTLE, M05-730, ACTG 5142 PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA04181FCFCCMEinfo.pdf http://podcast.peerviewpress.com/aids/PA04181FCCMEinfo.pdf Wed, 30 Apr 2008 14:40:48 -0400 Science no 00:00:00 AIDS, HIV, DHHS, CROI, lipoatrophy, SMART, CASTLE, M05-730, ACTG 5142 PeerView Press In this activity, experts in the treatment of HIV present the most current data on efficacy and safety of new and emerging agents for the management of treatment-experienced patients with HIV. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV present the most current data on efficacy and safety of new and emerging agents for the management of treatment-experienced patients with HIV. http://podcast.peerviewpress.com/aids/PA04547FCr381.mp3 http://podcast.peerviewpress.com/aids/PA04547FCr381.mp3 Thu, 17 Apr 2008 16:41:50 -0400 Science no 00:28:16 AIDS, HIV, CROI, raltegravir, maraviroc, etravirine, CCR5, DUET, BENCHMRK, MOTIVATE, tropism assay, treatment-experienced PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA04547FCCMEinfo.pdf http://podcast.peerviewpress.com/aids/PA04547FCCMEinfo.pdf Thu, 17 Apr 2008 16:41:45 -0400 Science no 00:00:00 AIDS, HIV, CROI, raltegravir, maraviroc, etravirine, CCR5, DUET, BENCHMRK, MOTIVATE, tropism assay, treatment-experienced PeerView Press In this activity, experts in the management of HIV review important issues to consider when individualizing antiretroviral therapy. The treatment of patients with HIV and comorbid HBV, HCV, or renal insufficiency, as well as management strategies for pregnant women are featured. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the management of HIV review important issues to consider when individualizing antiretroviral therapy. The treatment of patients with HIV and comorbid HBV, HCV, or renal insufficiency, as well as management strategies for pregnant women are featured. http://podcast.peerviewpress.com/aids/PA04154FCe011.mp3 http://podcast.peerviewpress.com/aids/PA04154FCe011.mp3 Tue, 08 Apr 2008 11:11:25 -0400 Science no 00:34:28 AIDS, HIV, DHHS, atazanavir, lopinavir, efavirenz, nevirapine, pregnancy, hepatitis, coinfection, zidovudine, lamivudine PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA04451FCCMEinfo.pdf http://podcast.peerviewpress.com/aids/PA04154FCCMEinfo.pdf Tue, 08 Apr 2008 11:10:22 -0400 Science no 00:00:00 AIDS, HIV, DHHS, atazanavir, lopinavir, efavirenz, nevirapine, pregnancy, hepatitis, coinfection, zidovudine, lamivudine PeerView Press In this activity, experts in the treatment of HIV present important issues regarding the management of HIV in women. The treatment of HIV in pregnant women is featured. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV present important issues regarding the management of HIV in women. The treatment of HIV in pregnant women is featured. http://podcast.peerviewpress.com/aids/PA04268FCr389.mp3 http://podcast.peerviewpress.com/aids/PA04268FCr389.mp3 Fri, 28 Mar 2008 15:47:42 -0400 Science no 00:22:58 HIV, pregnancy, contraception, DHHS, efavirenz, nelfinavir, antitretrovirals, mother-to-child transmission, zidovudine PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA04268FCCMEinfo.pdf http://podcast.peerviewpress.com/aids/PA04268FCCMEinfo.pdf Fri, 28 Mar 2008 15:47:41 -0400 Science no 00:00:00 HIV, pregnancy, contraception, DHHS, efavirenz, nelfinavir, antitretrovirals, mother-to-child transmission, zidovudine PeerView Press In this activity, experts in the treatment of HIV assess the most recent updates to the DHHS guidelines on HIV management and discuss how these recommendations should be implemented into clinical practice. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV assess the most recent updates to the DHHS guidelines on HIV management and discuss how these recommendations should be implemented into clinical practice. http://podcast.peerviewpress.com/aids/PA03620FC3r360.mp3 http://podcast.peerviewpress.com/aids/PA03620FC3r360.mp3 Wed, 27 Feb 2008 12:37:20 -0500 Science no 00:15:50 AIDS, HIV, DHHS, guidelines,CD4 counts, abacavir, atazanavir, lopinavir, efavirenz, tipranavir, darunavir, etravirine, nelfinavir, fosamprenavir, resistance testing, genotype, haplotype, hepatitis B coinfection, pregnancy PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA03620FC3CMEinfo.pdf http://podcast.peerviewpress.com/aids/PA03620FC3CMEinfo.pdf Wed, 27 Feb 2008 12:37:20 -0500 Science no 00:00:00 AIDS, HIV, DHHS, guidelines,CD4 counts, abacavir, atazanavir, lopinavir, efavirenz, tipranavir, darunavir, etravirine, nelfinavir, fosamprenavir, resistance testing, genotype, haplotype, hepatitis B coinfection, pregnancy PeerView Press In this activity, an expert in the treatment of HIV will examine key issues to consider when choosing an initial antiretroviral strategy. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, an expert in the treatment of HIV will examine key issues to consider when choosing an initial antiretroviral strategy. http://podcast.peerviewpress.com/aids/PA03539FC2p130.mp3 http://podcast.peerviewpress.com/aids/PA03539FC2p130.mp3 Tue, 15 Jan 2008 16:20:37 -0500 Science no 00:52:16 AIDS, HIV, NNRTI, PI, zidovudine, lamivudine, tenofovir, emtricitabine, abacavir, efavirenz, nevirapine, atazanavir, lopinavir, fosamprenavir, darunavir, ritonavir, treatment-naïve, 2NN, DHHS, IAS-USA PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA03539FC2CMEinfo.pdf http://podcast.peerviewpress.com/aids/PA03539FC2CMEinfo.pdf Tue, 15 Jan 2008 16:20:35 -0500 Science no 00:00:00 AIDS, HIV, NNRTI, PI, zidovudine, lamivudine, tenofovir, emtricitabine, abacavir, efavirenz, nevirapine, atazanavir, lopinavir, fosamprenavir, darunavir, ritonavir, treatment-naïve, 2NN, DHHS, IAS-USA PeerView Press In this activity, experts in the treatment of HIV present the most current data on efficacy and safety of new and emerging antiretroviral agents. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV present the most current data on efficacy and safety of new and emerging antiretroviral agents. http://podcast.peerviewpress.com/aids/PA04089FCs437.mp3 http://podcast.peerviewpress.com/aids/PA04089FCs437.mp3 Wed, 09 Jan 2008 13:36:10 -0500 Science no 00:34:34 AIDS, HIV, maraviroc, vicriviroc, raltegravir, elvitegravir, etravirine, TMC125, rilpivirine, TMC278, treatment experienced, CCR5, integrase inhibitors, ICAAC, IDSA, IAS, CXCR4, dual/mixed tropic, darunavir PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA04089FCCMEinfo.pdf http://podcast.peerviewpress.com/aids/PA04089FCCMEinfo.pdf Wed, 09 Jan 2008 13:36:08 -0500 Science no 00:00:00 AIDS, HIV, maraviroc, vicriviroc, raltegravir, elvitegravir, etravirine, TMC125, rilpivirine, TMC278, treatment experienced, CCR5, integrase inhibitors, ICAAC, IDSA, IAS, CXCR4, dual/mixed tropic, darunavir PeerView Press In this activity, an expert in the treatment of HIV uses a case-based method to discuss the most recent data on the safety and efficacy of fixed-dose antiretrovirals. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, an expert in the treatment of HIV uses a case-based method to discuss the most recent data on the safety and efficacy of fixed-dose antiretrovirals. http://podcast.peerviewpress.com/aids/PA03903FCp133.mp3 http://podcast.peerviewpress.com/aids/PA03903FCp133.mp3 Fri, 21 Dec 2007 09:44:10 -0500 Science no 00:35:00 CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, AIDS, HIV PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA03903FCCMECEinfo.pdf http://podcast.peerviewpress.com/aids/PA03903FCCMECEinfo.pdf Fri, 21 Dec 2007 09:44:06 -0500 Science no 00:00:00 CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, AIDS, HIV PeerView Press In this activity, experts in the treatment of HIV present current data on initial treatment options in HIV as well as efficacy and safety data on switching strategies. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV present current data on initial treatment options in HIV as well as efficacy and safety data on switching strategies. http://podcast.peerviewpress.com/aids/PA03538FC3s429.mp3 http://podcast.peerviewpress.com/aids/PA03538FC3s429.mp3 Fri, 07 Dec 2007 13:44:38 -0500 Science no 00:20:36 AIDS, HIV, antiretroviral, efavirenz, tenofovir, emtricitabine, zidovudine, lamivudine, atazanavir, fosamprenavir, lopinavir, ritonavir, darunavir, maraviroc, raltegravir, stavudine, abacavir, integrase inhibitor, CD4, DHHS, IAS-USA, cholesterol PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA03538FC3CMEinfo.pdf http://podcast.peerviewpress.com/aids/PA03538FC3CMEinfo.pdf Fri, 07 Dec 2007 13:44:36 -0500 Science no 00:00:00 AIDS, HIV, antiretroviral, efavirenz, tenofovir, emtricitabine, zidovudine, lamivudine, atazanavir, fosamprenavir, lopinavir, ritonavir, darunavir, maraviroc, raltegravir, stavudine, abacavir, integrase inhibitor, CD4, DHHS, IAS-USA, cholesterol PeerView Press In this activity, an expert in the treatment of HIV reviews initial treatment strategies in HIV and explores issues related to switching antiretroviral therapies. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, an expert in the treatment of HIV reviews initial treatment strategies in HIV and explores issues related to switching antiretroviral therapies. http://podcast.peerviewpress.com/aids/PA03539FC1p122.mp3 http://podcast.peerviewpress.com/aids/PA03539FC1p122.mp3 Thu, 29 Nov 2007 14:46:11 -0500 Science no 00:55:22 AIDS, HIV, treatment-naïve, treatment experienced, zidovudine, lamivudine, abacavir, tenofovir, emtricitabine, atazanavir, fosamprenavir, lopinavir, darunavir, efavirenz, nevirapine, etravirine PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA03539FC1CMEinfo.pdf http://podcast.peerviewpress.com/aids/PA03539FC1CMEinfo.pdf Thu, 29 Nov 2007 14:46:09 -0500 Science no 00:00:00 AIDS, HIV, treatment-naïve, treatment experienced, zidovudine, lamivudine, abacavir, tenofovir, emtricitabine, atazanavir, fosamprenavir, lopinavir, darunavir, efavirenz, nevirapine, etravirine PeerView Press In this activity, experts in the treatment of HIV present the most recent recommendations for creating maximally suppressive antiretroviral regimens for treatment-experienced patients with HIV. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV present the most recent recommendations for creating maximally suppressive antiretroviral regimens for treatment-experienced patients with HIV. http://podcast.peerviewpress.com/aids/PA03620FC2r340.mp3 http://podcast.peerviewpress.com/aids/PA03620FC2r340.mp3 Mon, 15 Oct 2007 14:00:36 -0400 Science no 00:21:14 AIDS, HIV, DHHS, treatment-experienced, atazanavir, lopinavir, efavirenz, tipranavir, darunavir, etravirine, marviroc, raltegravir, fosamprenavir, resistance testing, genotype, phenotype PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA03620FC2CMEinfo.pdf http://podcast.peerviewpress.com/aids/PA03620FC2CMEInfo.pdf Mon, 15 Oct 2007 14:00:34 -0400 Science no 00:00:00 CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, AIDS, HIV PeerView Press In this activity, experts in the treatment of HIV present the most current data on the risk of patients with HIV developing metabolic abnormalities while on antiretroviral therapy. Treatment options to manage these abnormalities are featured. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV present the most current data on the risk of patients with HIV developing metabolic abnormalities while on antiretroviral therapy. Treatment options to manage these abnormalities are featured. http://podcast.peerviewpress.com/aids/PA03530FCs419.mp3 http://podcast.peerviewpress.com/aids/PA03530FCs419.mp3 Tue, 09 Oct 2007 15:50:23 -0400 Science no 00:17:04 CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, AIDS, HIV PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA03530FCCMEinfo.pdf http://podcast.peerviewpress.com/aids/PA03530FCCMEinfo.pdf Tue, 09 Oct 2007 15:50:16 -0400 Science no 00:00:00 CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, AIDS, HIV PeerView Press In this activity, experts in the treatment of HIV present the most current data on fixed-dose antiretroviral agents. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV present the most current data on fixed-dose antiretroviral agents. http://podcast.peerviewpress.com/aids/PA03525FC2s422.mp3 http://podcast.peerviewpress.com/aids/PA03525FC2s422.mp3 Wed, 03 Oct 2007 10:49:52 -0400 Science no 00:41:49 AIDS, HIV, efavirenz, atazanavir, lopinavir, fosamprenavir, tenofovir, emtricitabine, zidovudine, lamivudine, study 934, study 903, KLEAN, LAKE, SHARE, ALERT, fixed-dose, antiretrovirals PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA03525FC2CMEinfo.pdf http://podcast.peerviewpress.com/aids/PA03525FC2CMEinfo.pdf Wed, 03 Oct 2007 10:48:58 -0400 Science no 00:00:00 AIDS, HIV, efavirenz, atazanavir, lopinavir, fosamprenavir, tenofovir, emtricitabine, zidovudine, lamivudine, study 934, study 903, KLEAN, LAKE, SHARE, ALERT, fixed-dose, antiretrovirals PeerView Press In this activity, experts in the treatment of HIV present the most current data on the efficacy and safety of newer and emerging antiretroviral agents used in the management of this condition. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV present the most current data on the efficacy and safety of newer and emerging antiretroviral agents used in the management of this condition. http://podcast.peerviewpress.com/aids/PA03928Fr344.mp3 http://podcast.peerviewpress.com/aids/PA03928FCr344.mp3 Tue, 18 Sep 2007 17:47:17 -0400 Science no 00:39:52 CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, AIDS, HIV PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA03928FCCMEinfo.pdf http://podcast.peerviewpress.com/aids/PA03928FCCMEinfo.pdf Tue, 18 Sep 2007 17:47:14 -0400 Science no 00:00:00 AIDS 2007, International AIDS Conference, 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, etravirine, darunavir, tipranavir, raltegravir, maraviroc, vicriviroc, elvitegravir, HIV, AIDS PeerView Press In this activity, experts in the treatment of HIV discuss the pros and cons of initiating antiretroviral therapy earlier than what is currently recommended. Issues of safety, resistance, and tolerability that need to be considered when selecting an initial treatment strategy are featured. The impact of antiretrovirals on lipid parameters and cardiovascular risk is discussed. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV discuss the pros and cons of initiating antiretroviral therapy earlier than what is currently recommended. Issues of safety, resistance, and tolerability that need to be considered when selecting an initial treatment strategy are featured. The impact of antiretrovirals on lipid parameters and cardiovascular risk is discussed. http://podcast.peerviewpress.com/aids/PA03538FC2r331.mp3 http://podcast.peerviewpress.com/aids/PA03538FC2r331.mp3 Thu, 09 Aug 2007 09:15:29 -0400 Science no 00:22:11 AIDS, HIV, antiretroviral, efavirenz, tenofovir, emtricitabine, zidovudine, lamivudine, atazanavir, fosamprenavir, lopinavir, ritonavir, CD4, DHHS, IAS-USA, cardiovascular, MI, dyslipidemia, diabetes, hypertension, ATHENA PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA03538FC2CMEinfo.pdf http://podcast.peerviewpress.com/aids/PA03538FC2CMEinfo.pdf Thu, 09 Aug 2007 09:15:11 -0400 Science no 00:00:00 AIDS, HIV, antiretroviral, efavirenz, tenofovir, emtricitabine, zidovudine, lamivudine, atazanavir, fosamprenavir, lopinavir, ritonavir, CD4, DHHS, IAS-USA, cardiovascular, MI, dyslipidemia, diabetes, hypertension, ATHENA PeerView Press In this activity, experts in the treatment of HIV discuss the incidence of HIV in adolescents and young adults. Management considerations for the treatment of HIV in young adults are featured. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV discuss the incidence of HIV in adolescents and young adults. Management considerations for the treatment of HIV in young adults are featured. http://podcast.peerviewpress.com/aids/PA03540FCr319.mp3 http://podcast.peerviewpress.com/aids/PA03540FCr319.mp3 Thu, 26 Jul 2007 11:51:56 -0400 Science no 00:17:17 AIDS, HIV, adolescents, young adults, efavirenz, tenofovir, emtricitabine, atazanavir, lopinavir, fosamprenavir, ritonavir, zidovudine, lamivudine, didanosine, contraception, pregnancy, pill burden, adherence, simplification, nevirapine, abacavir PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA03540FCCMEInfo.pdf http://podcast.peerviewpress.com/aids/PA03540FCCMEInfo.pdf Thu, 26 Jul 2007 11:51:34 -0400 Science no 00:00:00 AIDS, HIV, adolescents, young adults, efavirenz, tenofovir, emtricitabine, atazanavir, lopinavir, fosamprenavir, ritonavir, zidovudine, lamivudine, didanosine, contraception, pregnancy, pill burden, adherence, simplification, nevirapine, abacavir PeerView Press In this activity, experts in the treatment of HIV present recent data on the effects of antiretrovirals on metabolic and body-composition parameters. Cohort data on HIV and cardiovascular risk and emerging management strategies for dyslipidemia in HIV are featured. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV present recent data on the effects of antiretrovirals on metabolic and body-composition parameters. Cohort data on HIV and cardiovascular risk and emerging management strategies for dyslipidemia in HIV are featured. http://podcast.peerviewpress.com/aids/PA03538FC1s389.mp3 http://podcast.peerviewpress.com/aids/PA03538FC1s389.mp3 Thu, 17 May 2007 09:17:02 -0400 Science no 00:19:53 AIDS, HIV, metabolic, lipids, cholesterol, triglycerides, HDL, LDL, cardiovascular, body composition, atazanavir, efavirenz, lopinavir, fosamprenavir, tenofovir, stavudine, zidovudine, ezetimibe, leptin, BMS-089, ACTG-5142, SMART, D:A:D, ACTG 5095, KLEAN PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA03538FC1CMEinfo.pdf http://podcast.peerviewpress.com/aids/PA03538FC1CMEinfo.pdf Thu, 17 May 2007 09:16:39 -0400 Science no 00:00:00 AIDS, HIV, metabolic, lipids, cholesterol, triglycerides, HDL, LDL, cardiovascular, body composition, atazanavir, efavirenz, lopinavir, fosamprenavir, tenofovir, stavudine, zidovudine, ezetimibe, leptin, BMS-089, ACTG-5142, SMART, D:A:D, ACTG 5095, KLEAN PeerView Press In this activity, experts in the treatment of HIV use case-based scenarios to evaluate management strategies for treatment-experienced patients with HIV. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV use case-based scenarios to evaluate management strategies for treatment-experienced patients with HIV. http://podcast.peerviewpress.com/aids/PA03695FC2r281.mp3 http://podcast.peerviewpress.com/aids/PA03695FC2r281.mp3 Thu, 03 May 2007 15:04:07 -0400 Science no 00:38:35 AIDS, HIV, persistent low level viremia, treatment-experienced, treatment goals, viral suppression, efavirenz, atazanavir, fosamprenavir, lopinavir, saquinavir, tenofovir, darunavir, tenofovir, emtricitabine, nevirapine, ritonavir, DHHS, IAS-USA PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA03695FC2CMEinfo.pdf http://podcast.peerviewpress.com/aids/PA03695FC2CMEinfo.pdf Thu, 03 May 2007 15:03:54 -0400 Science no 00:00:00 AIDS, HIV, persistent low level viremia, treatment-experienced, treatment goals, viral suppression, efavirenz, atazanavir, fosamprenavir, lopinavir, saquinavir, tenofovir, darunavir, tenofovir, emtricitabine, nevirapine, ritonavir, DHHS, IAS-USA PeerView Press In this activity, experts in the treatment of HIV review the most recent guidelines for the initiation of antiretroviral therapy in HIV. Data used as evidence for some of the updated recommendations will be featured. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV review the most recent guidelines for the initiation of antiretroviral therapy in HIV. Data used as evidence for some of the updated recommendations will be featured. http://podcast.peerviewpress.com/aids/PA03620FC1r302.mp3 http://podcast.peerviewpress.com/aids/PA03620FC1r302.mp3 Fri, 27 Apr 2007 15:29:59 -0400 Science no 00:19:54 HIV, AIDS, DHHS, IAS-USA, guidelines, efavirenz, atazanavir, lopinavir, saquinavir, darunavir, tipranavir, tenofovir, emtricitabine, lamivudine, 3TC, abacavir, zidovudine, nevirapine, fosamprenavir, treatment naïve, treatment-experienced PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA03620FC1CMEinfo.pdf http://podcast.peerviewpress.com/aids/PA03620FC1CMEinfo.pdf Fri, 27 Apr 2007 15:29:39 -0400 Science no 00:00:00 HIV, AIDS, DHHS, IAS-USA, guidelines, efavirenz, atazanavir, lopinavir, saquinavir, darunavir, tipranavir, tenofovir, emtricitabine, lamivudine, 3TC, abacavir, zidovudine, nevirapine, fosamprenavir, treatment naïve, treatment-experienced PeerView Press In this activity, experts in the treatment of HIV present the most current data on the importance of optimum viral suppression for the management of treatment-experienced patients with HIV. The consequences of persistent low-level viremia are featured. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV present the most current data on the importance of optimum viral suppression for the management of treatment-experienced patients with HIV. The consequences of persistent low-level viremia are featured. http://podcast.peerviewpress.com/aids/PA03695FC1r280.mp3 http://podcast.peerviewpress.com/aids/PA03695FC1r280.mp3 Thu, 19 Apr 2007 16:39:41 -0400 Science no 00:46:06 AIDS, HIV, treatment-experienced, resistance, HIV RNA, viral load, DHHS, IAS-USA, enfuvirtide, darunavir, tipranavir, ritonavir, lopinavir, saquinavir, amprenavir, fosamprenavir, efavirenz, TMC125, TMC114, maraviroc, vicriviroc, MK-0518, GS9137, integrase PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA03695FC1CMEinfo.pdf http://podcast.peerviewpress.com/aids/PA03695FC1CMEinfo.pdf Thu, 19 Apr 2007 16:39:33 -0400 Science no 00:00:00 AIDS, HIV, treatment-experienced, resistance, HIV RNA, viral load, DHHS, IAS-USA, enfuvirtide, darunavir, tipranavir, ritonavir, lopinavir, saquinavir, amprenavir, fosamprenavir, efavirenz, TMC125, TMC114, maraviroc, vicriviroc, MK-0518, GS9137, integrase PeerView Press In this activity, experts in the treatment of HIV present recent data on efficacy and safety of fixed-dose antiretrovirals. The incorporation of many of these agents into evidence-based guidelines is featured. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV present recent data on efficacy and safety of fixed-dose antiretrovirals. The incorporation of many of these agents into evidence-based guidelines is featured. http://podcast.peerviewpress.com/aids/PA03525FCr275.mp3 http://podcast.peerviewpress.com/aids/PA03525FCr275.mp3 Fri, 16 Mar 2007 09:14:16 -0400 Science no 00:30:48 HIV, AIDS, fixed-dose, FDCs, zidovudine, lamivudine, efavirenz, tenofovir, emtricitabine, abacavir, NRTI, NNRTI, lopinavir, ritonavir, atazanavir, adherence, patient satisfaction, DHHS, IAS-USA, fixed-dose combination PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA03525FC1CMEinfo.pdf http://podcast.peerviewpress.com/aids/PA03525FC1CMEinfo.pdf Fri, 16 Mar 2007 09:13:44 -0400 Science no 00:00:00 HIV, AIDS, fixed-dose, FDCs, zidovudine, lamivudine, efavirenz, tenofovir, emtricitabine, abacavir, NRTI, NNRTI, lopinavir, ritonavir, atazanavir, adherence, patient satisfaction, DHHS, IAS-USA, fixed-dose combination PeerView Press In this case-based activity, an expert in the management of HIV discusses treatment issues regarding the management of special populations of patients with HIV. One case highlights issues in treating patients with elevated cardiovascular risk and one case highlights issues in treating women who are pregnant, and their neonates. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this case-based activity, an expert in the management of HIV discusses treatment issues regarding the management of special populations of patients with HIV. One case highlights issues in treating patients with elevated cardiovascular risk and one case highlights issues in treating women who are pregnant, and their neonates. http://podcast.peerviewpress.com/aids/PA03425FCp111.mp3 http://podcast.peerviewpress.com/aids/PA03425FCp111.mp3 Mon, 29 Jan 2007 11:23:02 -0500 Science no 00:26:51 AIDS, HIV, cardiovascular, lipids, elevated lipids, HDL, LDL, trigylcerides, pregnancy, efavirence, tenofovir, emtricitabine, atazanavir, lopinavir, ritonavir, nelfinavir, zidovudine, lamivuinde, neonates, mother-to-child transmission, Framingham PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA03425FCCMEinfo.pdf http://podcast.peerviewpress.com/aids/PA03425FCCMEinfo.pdf Mon, 29 Jan 2007 11:22:40 -0500 Science no 00:00:00 AIDS, HIV, cardiovascular, lipids, elevated lipids, HDL, LDL, trigylcerides, pregnancy, efavirence, tenofovir, emtricitabine, atazanavir, lopinavir, ritonavir, nelfinavir, zidovudine, lamivuinde, neonates, mother-to-child transmission, Framingham PeerView Press In this activity, experts in the treatment of HIV present recent data on the efficacy and safety of non-nucleoside reverse transcriptase inhibitors in the treatment of patients with HIV. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV present recent data on the efficacy and safety of non-nucleoside reverse transcriptase inhibitors in the treatment of patients with HIV. http://podcast.peerviewpress.com/aids/PA02184FC4s279.mp3 http://podcast.peerviewpress.com/aids/PA02184FC4s279.mp3 Thu, 14 Dec 2006 12:59:06 -0500 Science no 00:15:31 AIDS, HIV, NNRTIs, efavirenz, nevirapine, viral load, CD4, study 934, COOL, ACTG 5095, CLASS, study 903, hepatotoxicity PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA02184FC4CMEinfo.pdf http://podcast.peerviewpress.com/aids/PA02184FC4CMEinfo.pdf Thu, 14 Dec 2006 12:58:33 -0500 Science no 00:00:00 AIDS, HIV, NNRTIs, efavirenz, nevirapine, viral load, CD4, study 934, COOL, ACTG 5095, CLASS, study 903, hepatotoxicity PeerView Press In this activity, experts in the treatment of HIV present the most current data on efficacy and safety of protease inhibitors used for the management of treatment-naïve and treatment-experienced patients. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV present the most current data on efficacy and safety of protease inhibitors used for the management of treatment-naïve and treatment-experienced patients. http://podcast.peerviewpress.com/aids/PA02118FC3s273.mp3 http://podcast.peerviewpress.com/aids/PA02118FC3s273.mp3 Tue, 05 Dec 2006 15:16:05 -0500 Science no 00:15:12 AIDS, HIV, protease inhibitors, ICAAC, atazanavir, fosamprenavir, lopinavir, tipranavir, darunavir, ritonavir, treatment-naïve, treatment-experienced, lipids, HIV RNA, viral load, CD4, monotherapy PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA02118FC3CMEinfo.pdf http://podcast.peerviewpress.com/aids/PA02118FC3CMEinfo.pdf Tue, 05 Dec 2006 15:15:49 -0500 Science no 00:00:00 AIDS, HIV, protease inhibitors, ICAAC, atazanavir, fosamprenavir, lopinavir, tipranavir, darunavir, ritonavir, treatment-naïve, treatment-experienced, lipids, HIV RNA, viral load, CD4, monotherapy PeerView Press Using a case-based modality, an expert in HIV will address how to use evidence-based guidelines to help improve the management of patients with HIV. The treatment of newly-diagnosed patients and patients coinfected with HIV/HBV will be featured. Please be sure to view the accompanying (PDF) file for full CME/CE information. Using a case-based modality, an expert in HIV will address how to use evidence-based guidelines to help improve the management of patients with HIV. The treatment of newly-diagnosed patients and patients coinfected with HIV/HBV will be featured. http://podcast.peerviewpress.com/aids/PA03424FCp113.mp3 http://podcast.peerviewpress.com/aids/PA03424FC_p113_podcastaudio_QAApp_271106.mp3 Wed, 29 Nov 2006 16:34:04 -0500 Science no 00:29:55 AIDS, HIV, DHHS, IAS-USA, hepatitis B, efavirenz, lopinavir, NRTI, NNRTI, PI, atazanavir, fosamprenavir, saquinavir, tenofovir, emtrictiabine, lamivudine PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA03424FCCMEinfo.pdf http://podcast.peerviewpress.com/aids/PA03424FC_Podcast_linked_QAApp_291106.pdf Wed, 29 Nov 2006 16:33:53 -0500 Science no 00:00:00 AIDS, HIV, DHHS, IAS-USA, hepatitis B, efavirenz, lopinavir, NRTI, NNRTI, PI, atazanavir, fosamprenavir, saquinavir, tenofovir, emtrictiabine, lamivudine PeerView Press In this activity, experts in HIV/AIDS present recent data on NNRTI-containing treatment regimens in HIV, and discuss their role in clinical practice. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in HIV/AIDS present recent data on NNRTI-containing treatment regimens in HIV, and discuss their role in clinical practice. http://podcast.peerviewpress.com/aids/PA02184FC3idaug06a.mp3 http://podcast.peerviewpress.com/aids/PA02184FC3idaug06a.mp3 Thu, 16 Nov 2006 15:56:59 -0500 Science no 00:12:03 HIV, Antiretroviral therapy, NNRTI, Protease inhibitor, NRTI, HAART, Efavirenz, Nevirapine, Lopinavir, Ritonavir, Lamivudine, ACTG 5095, Tenofovir, Zidovudine, Emtricitabine, Tenofovir, Lipoatrophy, Etravirine, TMC125, Darunavir, TMC114, enfuvirtide PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA02184FC3CMEinfo.pdf http://podcast.peerviewpress.com/aids/PA02184FC3CMEinfo.pdf Thu, 16 Nov 2006 15:56:29 -0500 Science no 00:00:00 HIV, Antiretroviral therapy, NNRTI, Protease inhibitor, NRTI, HAART, Efavirenz, Nevirapine, Lopinavir, Ritonavir, Lamivudine, ACTG 5095, Tenofovir, Zidovudine, Emtricitabine, Tenofovir, Lipoatrophy, Etravirine, TMC125, Darunavir, TMC114, enfuvirtide PeerView Press Using a case-based modality, an expert in HIV will address issues of adherence and its impact on treatment in HIV. Please be sure to view the accompanying (PDF) file for full CME/CE information. Using a case-based modality, an expert in HIV will address issues of adherence and its impact on treatment in HIV. http://podcast.peerviewpress.com/aids/PA03423FCp112.mp3 http://podcast.peerviewpress.com/aids/PA03423FCp112.mp3 Thu, 09 Nov 2006 14:29:38 -0500 Science no 00:24:34 AIDS, HIV, efavirenz, tenofovir, emtricitabine, lopinavir, atazanavir, enfuvirtide, treatment-naïve, treatment-experienced, adherence, pill burden, pill count, once-daily, tipranavir, darunavir PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA03423FCCMEinfo.pdf http://podcast.peerviewpress.com/aids/PA03423FCCMEinfo.pdf Thu, 09 Nov 2006 14:29:23 -0500 Science no 00:00:00 AIDS, HIV, efavirenz, tenofovir, emtricitabine, lopinavir, atazanavir, enfuvirtide, treatment-naïve, treatment-experienced, adherence, pill burden, pill count, once-daily, tipranavir, darunavir PeerView Press In this activity, experts in HIV/AIDS present recent data on the efficacy and safety of simplified antiretroviral regimens in patients with HIV. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in HIV/AIDS present recent data on the efficacy and safety of simplified antiretroviral regimens in patients with HIV. http://podcast.peerviewpress.com/aids/PA02119FC3s260.mp3 http://podcast.peerviewpress.com/aids/PA02119FC3s260.mp3 Thu, 02 Nov 2006 16:34:52 -0500 Science no 00:15:28 HIV,Antiretroviral therapy,Simplified Regimens,Protease inhibitor,Lopinavir,Ritonavir,Efavirenz,Tenofovir,Zidovudine, Emtricitabine,Lamivudine,Fosamprenavir,NNRTI,NRTI,HAART,Adherence Once daily,ACTG 5142,MONARK study,COMET study,KalMo study,ZEST study PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA02119FC3CMEinfo.pdf http://podcast.peerviewpress.com/aids/PAO2119FC3CMEinfo.pdf Thu, 02 Nov 2006 16:34:34 -0500 Science no 00:00:00 HIV,Antiretroviral therapy,Simplified Regimens,Protease inhibitor,Lopinavir,Ritonavir,Efavirenz,Tenofovir,Zidovudine, Emtricitabine,Lamivudine,Fosamprenavir,NNRTI,NRTI,HAART,Adherence Once daily,ACTG 5142,MONARK study,COMET study,KalMo study,ZEST study PeerView Press In this activity, experts in the treatment of HIV participate in a panel discussion on the use of newer and emerging antiretroviral agents in the management of treatment-experienced patients with HIV. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV participate in a panel discussion on the use of newer and emerging antiretroviral agents in the management of treatment-experienced patients with HIV. http://podcast.peerviewpress.com/aids/PA03511FCinR224.mp3 http://podcast.peerviewpress.com/aids/PA03511FCinR224.mp3 Tue, 17 Oct 2006 16:23:18 -0400 Science no 00:47:42 HIV, AIDS, TMC125, TMC114, darunavir, etravirine, tipranavir, enfuvirtide, MK-0518, CCR5, CXCR4, PIs, treatment-experienced, resistance PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/aids/PA03511FCCMEinfo.pdf http://podcast.peerviewpress.com/aids/PA03511FCCMEinfo.pdf Tue, 17 Oct 2006 16:23:06 -0400 Science no 00:00:00 HIV, AIDS, TMC125, TMC114, darunavir, etravirine, tipranavir, enfuvirtide, MK-0518, CCR5, CXCR4, PIs, treatment-experienced, resistance, PeerView Press In this activity, experts in HIV/AIDS present recent data on the efficacy and safety of protease inhibitor-based regimens in both treatment-naïve and -experienced patients with HIV. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in HIV/AIDS present recent data on the efficacy and safety of protease inhibitor-based regimens in both treatment-naïve and -experienced patients with HIV. http://podcast.peerviewpress.com/aids/PA02118FCidaug06b.mp3 http://podcast.peerviewpress.com/aids/PA02118FC2idaug06b.mp3 Thu, 05 Oct 2006 09:55:22 -0400 Science no 00:14:27 HIV, Antiretroviral therapy, Protease inhibitor, Lopinavir, Ritonavir, Atazanavir, Darunavir, TMC114, Fosamprenavir, Efavirenz, Enfuvirtide, Nelfinavir, Zidovudine, Lamivudine, Tenofovir, Stavudine, NRTI, NNRTI, HAART, ACTG 5142, Zidovudine, Lamivudine PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/aids/PA02118FCCMEinfo.pdf http://podcast.peerviewpress.com/aids/PA02118FC2CMEinfo.pdf Thu, 05 Oct 2006 09:54:46 -0400 Science no 00:00:00 HIV, Antiretroviral therapy, Protease inhibitor, Lopinavir, Ritonavir, Atazanavir, Darunavir, TMC114, Fosamprenavir, Efavirenz, Enfuvirtide, Nelfinavir, Zidovudine, Lamivudine, Tenofovir, Stavudine, NRTI, NNRTI, HAART, ACTG 5142, Zidovudine, Lamivudine PeerView Press In this activity, experts discuss the treatment of patients coinfected with HIV and chronic hepatitis B. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts discuss the treatment of patients coinfected with HIV and chronic hepatitis B. http://podcast.peerviewpress.com/aids/PA02122FC4inR146.mp3 http://podcast.peerviewpress.com/aids/PA02122FC4inR146.mp3 Thu, 28 Sep 2006 11:36:20 -0400 Science no 00:19:49 AIDS, HIV, Hepatitis B, tenofovir, emtricitabine, lamivudine, interferon, pegylated interferon, entecavir, adefovir, coinfected, DHHS guidelines PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/aids/PA02122FC4CMEinfo.pdf http://podcast.peerviewpress.com/aids/PA02122FC4CMEinfo.pdf Thu, 28 Sep 2006 11:35:41 -0400 Science no 00:00:00 AIDS, HIV, Hepatitis B, tenofovir, emtricitabine, lamivudine, interferon, pegylated interferon, entecavir, adefovir, coinfected, DHHS guidelines PeerView Press In this activity, experts in the treatment of HIV discuss treatment issues specific to women of reproductive age. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV discuss treatment issues specific to women of reproductive age. http://podcast.peerviewpress.com/aids/PA02122FC3inR145.mp3 http://podcast.peerviewpress.com/aids/PA02122FC3inR145.mp3 Thu, 17 Aug 2006 12:06:09 -0400 Science no 00:15:21 AIDS, HIV, pregnancy, mother-to-child transmission, reproductive age, oral contraceptives, antiretrovirals, intrapartum PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/aids/PA02122FC3CMEinfo.pdf http://podcast.peerviewpress.com/aids/PA02122FC3CMEinfo.pdf Thu, 17 Aug 2006 12:05:27 -0400 Science no 00:00:00 AIDS, HIV, pregnancy, mother-to-child transmission, reproductive age, oral contraceptives, antiretrovirals, intrapartum PeerView Press In this activity, experts in the treatment of HIV present recent data on fixed-dose antiretroviral combinations for the management of this condition. The use of these agents to simplify treatment of HIV is featured. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV present recent data on fixed-dose antiretroviral combinations for the management of this condition. The use of these agents to simplify treatment of HIV is featured. http://podcast.peerviewpress.com/aids/PA02278FCinR182.mp3 http://podcast.peerviewpress.com/aids/PA02278FCinR182.mp3 Tue, 25 Jul 2006 08:45:40 -0400 Science no 00:21:02 AIDS, HIV, fixed-dose, adherence, convenience, efavirenz, tenofovir, emtricitabine, abacavir, lamivudine, lopinavir, zidovudine, antiretrovirals PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/aids/PA02278FCCMEinfo.pdf http://podcast.peerviewpress.com/aids/PA02278FCCMEinfo.pdf Tue, 25 Jul 2006 08:45:11 -0400 Science no 00:00:00 AIDS, HIV, fixed-dose, adherence, convenience, efavirenz, tenofovir, emtricitabine, abacavir, lamivudine, lopinavir, zidovudine, antiretrovirals PeerView Press In this activity, experts in the treatment of HIV review the most recent changes in the DHHS guideline recommendations for the management of this condition. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV review the most recent changes in the DHHS guideline recommendations for the management of this condition. http://podcast.peerviewpress.com/aids/PA02120FC2inR142.mp3 http://podcast.peerviewpress.com/aids/PA02120FC2inR142.mp3 Mon, 24 Jul 2006 13:41:01 -0400 Science no 00:15:05 AIDS, HIV, DHHS, resistance, genotype, mutations, treatment interruption, STI PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/aids/PA02120FC2CMEinfo.pdf http://podcast.peerviewpress.com/aids/PA02120FC2CMEinfo.pdf Mon, 24 Jul 2006 13:39:38 -0400 Science no 00:00:00 AIDS, HIV, DHHS, resistance, genotype, mutations, treatment interruption, STI PeerView Press In this activity, experts in the treatment of HIV discuss several factors to consider when choosing an NNRTI-based regimen. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV discuss several factors to consider when choosing an NNRTI-based regimen. http://podcast.peerviewpress.com/aids/PA02184FC2inR102.mp3 http://podcast.peerviewpress.com/aids/PA02184FC2inR102.mp3 Wed, 05 Jul 2006 11:17:51 -0400 Science no 00:12:06 HIV, AIDS, NNRTIs, efavirenz, nevirapine, delavirdine, TMC125, pregnancy, treatment-naïve, treatment-experienced, DHHS guidelines, virologic resistance PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/aids/PA02184FC2CMEinfo.pdf http://podcast.peerviewpress.com/aids/PA02184FC2CMEinfo.pdf Wed, 05 Jul 2006 11:17:39 -0400 Science no 00:00:00 HIV, AIDS, NNRTIs, efavirenz, nevirapine, delavirdine, TMC125, pregnancy, treatment-naïve, treatment-experienced, DHHS guidelines, virologic resistance PeerView Press In this activity, experts discuss the treatment of HIV and HCV in those patients coinfected with both. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts discuss the treatment of HIV and HCV in those patients coinfected with both. http://podcast.peerviewpress.com/aids/PA02122FC2inR144.mp3 http://podcast.peerviewpress.com/aids/PA02122FC2inR144.mp3 Tue, 06 Jun 2006 14:14:15 -0400 Science no 00:19:22 Hepatitis C,HIV,antiretroviral regimen,atazanavir,coinfection,efavirenz,lamivudine,tenofovir,AZT,emtricitabine,lopinavir,ritonavir,3TC,FTC,TDF,ddI,ddC,D4T,stavudine,zalcitabine,didanosine,liver toxicity,DHHS guidelines,Study 934,once-daily regimens PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/aids/PA02122FC2CMEinfo.pdf http://podcast.peerviewpress.com/aids/PA02122FC2CMEinfo.pdf Tue, 06 Jun 2006 14:14:10 -0400 Science no 00:00:00 Hepatitis C,HIV,antiretroviral regimen,atazanavir,coinfection,efavirenz,lamivudine,tenofovir,AZT,emtricitabine,lopinavir,ritonavir,3TC,FTC,TDF,ddI,ddC,D4T,stavudine,zalcitabine,didanosine,liver toxicity,DHHS guidelines,Study 934,once-daily regimens PeerView Press In this activity, experts in the treatment of HIV present the most current data on efficacy and safety of once-daily agents and regimens used in the management of this condition. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV present the most current data on efficacy and safety of once-daily agents and regimens used in the management of this condition. http://podcast.peerviewpress.com/aids/PA02119FC2inR139.mp3 http://podcast.peerviewpress.com/aids/PA02119FC2inR139.mp3 Thu, 01 Jun 2006 13:39:24 -0400 Science no 00:14:15 AIDS,HIV,atazanavir,lopinavir,ritonavir,once-daily,QD,tenofovir,emtricitabine,lamivudine,fosamprenavir,efavirenz,didanosine,3TC,TDF/FTC,abacavir,3TC/abacavir,fixed-dose,Study 934,HIV RNA,viral load,treatment-naïve,treatment-experienced,boosted,unboosted PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/aids/PA02119FC2CMEinfo.pdf http://podcast.peerviewpress.com/aids/PA02119FCCMEinfo.pdf Thu, 01 Jun 2006 13:39:17 -0400 Science no 00:00:00 AIDS,HIV,atazanavir,lopinavir,ritonavir,once-daily,QD,tenofovir,emtricitabine,lamivudine,fosamprenavir,efavirenz,didanosine,3TC,TDF/FTC,abacavir,3TC/abacavir,fixed-dose,Study 934,HIV RNA,viral load,treatment-naïve,treatment-experienced,boosted,unboosted PeerView Press In this activity, experts in the treatment of HIV present recent efficacy and safety data on new and emerging protease inhibitors and non-nucleoside reverse transcriptase inhibitors. A discussion on the evolving principles for managing treatment-experienced patients is featured. Based on data presented at the 12th Annual BHIVA Meeting March 29-April 1, 2006, Brighton, UK. This content is not a publication of, sanctioned by, or an official part of the 12th Annual British HIV Association Meeting. The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView Press or any of its supporters. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV present recent efficacy and safety data on new and emerging protease inhibitors and non-nucleoside reverse transcriptase inhibitors. A discussion on the evolving principles for managing treatment-experienced patients is featured. Based on data presented at the 12th Annual BHIVA Meeting March 29-April 1, 2006, Brighton, UK. This content is not a publication of, sanctioned by, or an official part of the 12th Annual British HIV Association Meeting. The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView Press or any of its supporters. http://podcast.peerviewpress.com/aids/PA03211FCidmar06a.mp3 http://podcast.peerviewpress.com/aids/PA03211FCidmar06a.mp3 Tue, 30 May 2006 13:35:19 -0400 Science no 00:25:16 HIV,AIDS,emerging treatment,antiretroviral therapy,tipranavir,TMC114,TMC125,TMC278,darunavir,etravirine,ritonavir,antiretroviral,brecanavir,POWER,RESIST,POWER 1,POWER 2,POWER 3,RESIST 1,RESIST 2,treatment-experienced,virologic resistance,treatment failure PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/aids/PA03211FCCMEinfo.pdf http://podcast.peerviewpress.com/aids/PA03211FCCMEinfo.pdf Tue, 30 May 2006 13:29:15 -0400 Science no 00:00:00 HIV,AIDS,emerging treatment,antiretroviral therapy,tipranavir,TMC114,TMC125,TMC278,darunavir,etravirine,ritonavir,antiretroviral,brecanavir,POWER,RESIST,POWER 1,POWER 2,POWER 3,RESIST 1,RESIST 2,treatment-experienced,virologic resistance,treatment failure PeerView Press In this activity, experts in the treatment of HIV present recent data on the efficacy and safety of protease inhibitors used in the management of this condition. Novel uses of these agents will be featured. Based on data presented at the 13th Conference on Retroviruses and Opportunistic Infections, February 5-8, 2006, Denver, Colorado. This content is not a publication of, sanctioned by, or an official part of CROI 2006. The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView Press or any of its supporters. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV present recent data on the efficacy and safety of protease inhibitors used in the management of this condition. Novel uses of these agents will be featured. Based on data presented at the 13th Conference on Retroviruses and Opportunistic Infections, February 5-8, 2006, Denver, Colorado. This content is not a publication of, sanctioned by, or an official part of CROI 2006. The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView Press or any of its supporters. http://podcast.peerviewpress.com/aids/PA02118FCidfeb06b.mp3 http://podcast.peerviewpress.com/aids/PA02118FCidfeb06b.mp3 Fri, 05 May 2006 13:39:45 -0400 Science no 00:14:13 AIDS,HIV,protease inhibitors,protease inhibitor,atazanavir,ritonavir,treatment-naive,treatment-experienced,ritonavir-boosted,HIV RNA,viral load,CD4,noninferiority study,hyperbilirubinemia,bilirubin,lipids,tipranavir,RESIST,RESIST 1,RESIST 2,BMS 089,TMC114 PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/aids/PA02118FCCMEinfo.pdf http://podcast.peerviewpress.com/aids/PA02118FCCMEinfo.pdf Fri, 05 May 2006 13:39:00 -0400 Science no 00:00:00 AIDS,HIV,protease inhibitors,protease inhibitor,atazanavir,ritonavir,treatment-naive,treatment-experienced,ritonavir-boosted,HIV RNA,viral load,CD4,noninferiority study,hyperbilirubinemia,bilirubin,lipids,tipranavir,RESIST,RESIST 1,RESIST 2,BMS 089,TMC114 PeerView Press In this activity, experts in the treatment of HIV present recent data on efficacy and safety of once-daily antiretroviral agents and once-daily regimens used in the management of this condition. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV present recent data on efficacy and safety of once-daily antiretroviral agents and once-daily regimens used in the management of this condition. http://podcast.peerviewpress.com/aids/PA02119FC1idfeb06c.mp3 http://podcast.peerviewpress.com/aids/PA02119FC1idfeb06c.mp3 Tue, 25 Apr 2006 15:28:45 -0400 Science no 00:16:20 HIV,Once-Daily,adherence,monotherapy,pilot study,prospective study,atazanavir/r,atazanavir,stavudine-ER,lamivudine,virologic failure,lopinavir/r,HIV RNA,efavirenz,NRTI,antiretroviral-naïve,abacavir,Safety,didanosine,fosamprenavir PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/aids/PA02119FC1CMEinfo.pdf http://podcast.peerviewpress.com/aids/PA02119FC1CMEinfo.pdf Tue, 25 Apr 2006 15:28:38 -0400 Science no 00:00:00 HIV,Once-Daily,adherence,monotherapy,pilot study,prospective study,atazanavir/r,atazanavir,stavudine-ER,lamivudine,virologic failure,lopinavir/r,HIV RNA,efavirenz,NRTI,antiretroviral-naïve,abacavir,Safety,didanosine,fosamprenavir PeerView Press In this activity, experts in the treatment of HIV present the most current data on efficacy and safety of non-nucleoside reverse transcriptase inhibitors. Data on emerging options for patients with NNRTI resistance are featured. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of HIV present the most current data on efficacy and safety of non-nucleoside reverse transcriptase inhibitors. Data on emerging options for patients with NNRTI resistance are featured. http://podcast.peerviewpress.com/aids/PA02184FC1idfeb06d.mp3 http://podcast.peerviewpress.com/aids/PA02184FC1idfeb06d.mp3 Mon, 17 Apr 2006 09:46:47 -0400 Science no 00:13:38 HIV,AIDS,efavirenz,nevirapine,NNRTI,NRTI,TMC125 PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/aids/PA02184FC1CMEInfo.pdf http://podcast.peerviewpress.com/aids/PA02184FC1CMEInfo.pdf Mon, 17 Apr 2006 09:45:47 -0400 Science no 00:00:00 HIV,AIDS,efavirenz,nevirapine,NNRTI,NRTI,TMC125 PeerView Press In this activity, experts in the management of HIV review special issues that one needs to consider when treating patients who are current or former injection drug users. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the management of HIV review special issues that one needs to consider when treating patients who are current or former injection drug users. http://podcast.peerviewpress.com/aids/PA02122FC1inR143.mp3 http://podcast.peerviewpress.com/aids/PA02122FC1inR143.mp3 Thu, 09 Mar 2006 15:21:07 -0500 Science no 00:11:29 HIV,once-daily,efavirenz,abacavir,anemia,atazanavir,zidovudine,lamivudine,tenofovir,methadone,emtricitabine,delavirdine,enfuvirtide,lopinavir/r,SWAN study,cytochrome P450,noninferiority,prospective,HBV,hypersensitivity,lactic acidosis,lipids PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/aids/PA02122FC1CMEinfo.pdf http://podcast.peerviewpress.com/aids/PA02122FC1CMEinfo.pdf Thu, 09 Mar 2006 15:21:01 -0500 Science no 00:00:00 HIV,once-daily,efavirenz,abacavir,anemia,atazanavir,zidovudine,lamivudine,tenofovir,methadone,emtricitabine,delavirdine,enfuvirtide,lopinavir/r,SWAN study,cytochrome P450,noninferiority,prospective,HBV,hypersensitivity,lactic acidosis,lipids PeerView Press In this activity, experts in the management of HIV review the most recent recommendations from the Department of Health and Human Services for the management of adults and adolescents with HIV. Changes from prior recommendations will be emphasized. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the management of HIV review the most recent recommendations from the Department of Health and Human Services for the management of adults and adolescents with HIV. Changes from prior recommendations will be emphasized. http://podcast.peerviewpress.com/aids/PA02120FC1inR141.mp3 http://podcast.peerviewpress.com/aids/PA02120FC1inR141.mp3 Fri, 10 Feb 2006 10:17:54 -0500 Science no 00:12:56 CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/aids/PA02120FC1CMEinfo.pdf http://podcast.peerviewpress.com/aids/PA02120FC1CMEinfo.pdf Fri, 10 Feb 2006 10:17:45 -0500 Science no 00:00:00 CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE